Clinical Trials
52 trialsTesting of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
M.D. Anderson Cancer Center
EGR2
Assistance Publique - Hôpitaux de Paris
UP-RISING
AbbVie
COTIRA
University of Aarhus
GREAT1
University of Pittsburgh
Comprehensive Segmental Revision System
Zimmer Biomet
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
Bristol-Myers Squibb
DANBIO
Bristol-Myers Squibb
PRESAGE
Assistance Publique - Hôpitaux de Paris
Comparative Autoantibody and Immunologic Cell Marker Study
Emory University
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Pfizer
EMPOWER
Future Genetics Limited
OTIS Humira Pregnancy Registry
University of California, San Diego
OTIS Cimzia Pregnancy Registry
University of California, San Diego
HRP
Exactech
QUANTUM
VitaMed Research LLC
Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.
Aalborg University Hospital
Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.
Pfizer
PPM:RANT
Brigham and Women's Hospital
PatientSpot Formerly Known as ArthritisPower
Global Healthy Living Foundation
LTC
King's College London
Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease
Peking University Third Hospital
Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis
Sohag University
STAR-RA-Cancer
Brigham and Women's Hospital
A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents
Bristol-Myers Squibb
TNF-alpha
University of Sulaimani
Impact of Anti-citrullinated Protein Antibody Status on Treatment Response and Treatment Persistence in Participants With Rheumatoid Arthritis (RA) Who Are Treated With Abatacept or Tumor Necrosis Factor Inhibitors in Australia
Bristol-Myers Squibb
DREAM
Brigham and Women's Hospital
MicroSpA & RA
Universidade Nova de Lisboa
NexT
UCB Pharma
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Mayo Clinic
PROCID-DCH
University of Southern Denmark
A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Sungkyunkwan University
GITR
Benha University
PASSRRA
Hikma Pharmaceuticals LLC
T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
Imperial College London
Re-Bone
University of Erlangen-Nürnberg Medical School
Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBase
University Hospital, Toulouse
A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.
Hoffmann-La Roche
Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy
Hoffmann-La Roche
An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis
Hoffmann-La Roche
Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France
Centre Hospitalier Universitaire de Nīmes
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent
Hoffmann-La Roche
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB)
Hoffmann-La Roche
FasT
UCB Pharma
A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)
Merck Sharp & Dohme LLC
An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.
Centocor Ortho Biotech Services, L.L.C.
A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea
Janssen Korea, Ltd., Korea
Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis
Radboud University Medical Center